SHANGHAI, China, April 03, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug

To Observe International Day of Conscience on April 5 “Let us sow the seeds of conscience in education, saving the world with conscience education.” ~ Dr. Hong, Tao-Tze, president of FOWPAL LOS ANGELES, April 02, 2022 (GLOBE NEWSWIRE) — April 5, 2022 marks the third UN-designated International Day of Conscience, and the Federation of World […]